EUVIMEDEUVIMED entdecken
Crossref

Dissecting Parameters Contributing to the Underprediction of Aldehyde Oxidase-Mediated Metabolic Clearance of Drugs

Sandhya Subash iD, Dilip K Singh, Deepak S Ahire iD, S Cyrus Khojasteh, Bernard P Murray, Michael A Zientek, Robert S Jones iD, Priyanka Kulkarni, Bill J Smith, Scott Heyward iD, Ciarán N Cronin, Bhagwat Prasad iD

Drug Metabolism and Disposition · 2023

DOI: 10.1124/dmd.123.001379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2023. Verfasst von Sandhya Subash und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Washington State University (WSU), Spokane, Washington (S.S., D.K.S., D.S.A., B.P.); Drug Metabolism and Pharm…. Hauptthemen laut MEDLINE: Aldehyde Oxidase, Carbamates. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigated the effect of variability and instability in aldehyde oxidase (AO) content and activity on the scaling of in vitro metabolism data. AO content and activity in human liver cytosol (HLC) and five recombinant human AO preparations (rAO) were determined using targeted proteomics and carbazeran oxidation assay, respectively. AO content was highly variable as indicated by the relative expression factor (REF; i.e., HLC to rAO content) ranging from 0.001 to 1.7 across different in vitro systems. The activity of AO in HLC degrades at a 10-fold higher rate in the presence of the substrate as compared with the activity performed after preincubation without substrate. To scale the metabolic activity from rAO to HLC, a protein-normalized activity factor (pnAF) was proposed wherein the activity was corrected by AO content, which revealed up to sixfold higher AO activity in HLC versus rAO systems. A similar value of pnAF was observed for another substrate, ripasudil. Physiologically based pharmacokinetic (PBPK) modeling revealed a significant additional clearance (CL; 66%), which allowed for the successful prediction of in vivo CL of four other substrates, i.e., O-benzyl guanine, BIBX1382, zaleplon, and zoniporide. For carbazeran, the metabolite identification study showed that the direct glucuronidation may be contributing to around 12% elimination. Taken together, this study identified differential protein content, instability of in vitro activity, role of additional AO clearance, and unaccounted metabolic pathways as plausible reasons for the underprediction of AO-mediated drug metabolism. Consideration of these factors and integration of REF and pnAF in PBPK models will allow better prediction of AO metabolism. SIGNIFICANCE STATEMENT: This study elucidated the plausible reasons for the underprediction of aldehyde oxidase (AO)-mediated drug metabolism and provided recommendations to address them. It demonstrated that integrating protein content and activity differences and accounting for the loss of AO activity, as well as consideration of extrahepatic clearance and additional pathways, would improve the in vitro to in vivo extrapolation of AO-mediated drug metabolism using physiologically based pharmacokinetic modeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aldehyde OxidaseCarbamatesHumansKineticsMetabolic Clearance RateLiver

Substanzen

carbazeranAldehyde OxidaseCarbamates

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Washington State University (WSU), Spokane, Washington (S.S., D.K.S., D.S.A., B.P.); Drug Metabolism and Pharmacokinetics, Genentech Inc., South San Francisco, California (S.C.K.,…

ORCID-Profile: Sandhya Subash, Deepak S Ahire, Robert S Jones, Scott Heyward, Bhagwat Prasad

Zitieren

APA

Subash, S., Singh, D. K., Ahire, D. S., Khojasteh, S. C., Murray, B. P., Zientek, M. A., Jones, R. S., Kulkarni, P., Smith, B. J., Heyward, S., Cronin, C. N., & Prasad, B. (2023). Dissecting Parameters Contributing to the Underprediction of Aldehyde Oxidase-Mediated Metabolic Clearance of Drugs. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.123.001379

Vancouver

Subash S, Singh DK, Ahire DS, Khojasteh SC, Murray BP, Zientek MA, et al. Dissecting Parameters Contributing to the Underprediction of Aldehyde Oxidase-Mediated Metabolic Clearance of Drugs. Drug Metabolism and Disposition. 2023. doi:10.1124/dmd.123.001379

BibTeX
@article{Subash2023,
  author = {Subash, Sandhya and Singh, Dilip K and Ahire, Deepak S and Khojasteh, S Cyrus and Murray, Bernard P and Zientek, Michael A and Jones, Robert S and Kulkarni, Priyanka and Smith, Bill J and Heyward, Scott and Cronin, Ciarán N and Prasad, Bhagwat},
  title = {Dissecting Parameters Contributing to the Underprediction of Aldehyde Oxidase-Mediated Metabolic Clearance of Drugs},
  journal = {Drug Metabolism and Disposition},
  year = {2023},
  doi = {10.1124/dmd.123.001379}
}
Kostenlos starten →